Inhibition of breast cancer growth with the combination of lapatinib and an ADAM protease inhibitor

被引：0
|
作者：
Witters, L. M.
Scherle, P. A.
Friedman, S. M.
Redman, J.
Fridman, J. S.
Caulder, E.
Lipton, A.
机构：
[1] Penn State Univ, Coll Med, Hershey, PA USA
[2] Incyte Corp, Wilmington, DE USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [1] Inhibition of growth of human breast cancer cell lines with the combination of an mTOR inhibitor and a Bcl-2 inhibitor
    Wilson, Matthew
    Witters, Lois
    Lane, Heidi
    Lipton, Allan
    CANCER RESEARCH, 2006, 66 (08)
  • [2] Growth inhibition in human breast cancer cells with the combination of a PKC inhibitor and zoledronic acid.
    Witters, LM
    Green, J
    Seaman, J
    Lipton, A
    Milton, S
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S166 - S166
  • [3] Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
    Simiczyjew, Aleksandra
    Dratkiewicz, Ewelina
    Van Troys, Marleen
    Ampe, Christophe
    Styczen, Ilona
    Nowak, Dorota
    CANCERS, 2018, 10 (09)
  • [4] Doxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast Cancer
    Wang, Huiyuan
    Li, Feng
    Du, Chengan
    Wang, Huixin
    Mahato, Ram I.
    Huang, Yongzhuo
    MOLECULAR PHARMACEUTICS, 2014, 11 (08) : 2600 - 2611
  • [5] Lapatinib, trastuzumab or the combination added to neoadjuvant chemotherapy for breast cancer
    Liang, Quan
    Fu, Qiang
    Li, Wei
    You, Jiacong
    Zhao, Zhanchao
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2016, 11 (04) : 863 - 868
  • [6] Lapatinib: a tyrosine kinase inhibitor with a clinical role in breast cancer
    Mukherjee, A.
    Dhadda, A. S.
    Shehata, M.
    Chan, Stephen
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (13) : 2189 - 2204
  • [7] Lapatinib: A dual tyrosine kinase inhibitor for metastatic breast cancer
    Paul, Betsy
    Trovato, James A.
    Thompson, Jennifer
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (18) : 1703 - 1710
  • [8] Dual kinase inhibition in the treatment of breast cancer: Initial experience with the EGFR/ErbB-2 inhibitor lapatinib
    Burris, HA
    ONCOLOGIST, 2004, 9 : 10 - 15
  • [9] ADAM protease inhibition overcomes resistance of breast cancer stem-like cells to γδ T cell immunotherapy
    Dutta, Indrani
    Dieters-Castator, Dylan
    Papatzimas, James W.
    Medina, Anais
    Schueler, Julia
    Derksen, Darren J.
    Lajoie, Gilles
    Postovit, Lynne-Marie
    Siegers, Gabrielle M.
    CANCER LETTERS, 2021, 496 : 156 - 168
  • [10] Lapatinib in breast cancer
    Bilancia, D.
    Rosati, G.
    Dinota, A.
    Germano, D.
    Romano, R.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 26 - 30
12345